A Journal of Nutrition study found cholesterol and fat-mass benefits from whole grain dieting.
A randomized trial on Danish women adds to the scientific discussion around whole grain products for improving body composition.
Researchers recruited 79 overweight and obese postmenopausal women to consume either whole grain products or refined wheat products for 12 weeks following 2 weeks of consuming refined wheat. Measures of body composition-including body weight, fat mass, and cholesterol-were performed at baseline, 6 weeks, and 12 weeks.
“The prevalence of women with features of metabolic syndrome increases after the onset of menopause,” wrote the study’s author, “which is linked with substantial metabolic changes emerging with estrogen deficiency.”
Analysis of both wheat-eating periods determined that changes in body weight did not differ between the two groups. But body fat decreased more in the whole grain group (3%) than it did in the refined wheat group (2.1%). If that difference doesn’t look big to you, consider the 5–6% reduction in total and LDL (“bad”) cholesterol experienced by the whole grain group compared to zero cholesterol changes in the refined wheat group.
The researchers claim that while published clinical trials on whole grain diets have produced conflicting results on body composition, this study adds to increasing evidence of a beneficial role for whole grains on fat mass reduction.
The study, published in the Journal of Nutrition, was supported by the European Commission and the University of Copenhagen.
The impact of GLP-1 on supplements, functional foods, and retail: a webinar from CRN
January 29th 2025The recent CRN webinar discussed GLP-1 medications' impact on supplements, functional foods, and retail, covering consumer trends, global market insights, retailer strategies, industry implications, and future opportunities for innovation.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
Steve Mister on CRN's ongoing lawsuit against New York State
October 11th 2024Nutritional Outlook spoke to The Council for Responsible Nutrition's president and CEO, Steve Mister, at its annual meeting, Convergence '24. Mister discussed the latest in its ongoing lawsuit against NY State's law banning the sale of weight management and muscle building products to minors.